Pages that link to "Q76390308"
Jump to navigation
Jump to search
The following pages link to Stem cells for Parkinson disease and ALS: replacement or protection? (Q76390308):
Displaying 19 items.
- Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1 (Q24314633) (← links)
- Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives (Q26995278) (← links)
- Protection of visual functions by human neural progenitors in a rat model of retinal disease (Q33280574) (← links)
- GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. (Q33292690) (← links)
- Chromosome 7 and 19 trisomy in cultured human neural progenitor cells (Q33515583) (← links)
- Regionally-specified second trimester fetal neural stem cells reveals differential neurogenic programming (Q34121992) (← links)
- Neuron-Like Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells (Q35003377) (← links)
- Stem cell transplantation as a therapeutic strategy for traumatic brain injury (Q36368256) (← links)
- Differentiation of CD133 stem cells from amyotrophic lateral sclerosis patients into preneuron cells (Q36861763) (← links)
- Contributions of non-human primates to neuroscience research (Q37122421) (← links)
- Comparative effects between bone marrow and mesenchymal stem cell transplantation in GDNF expression and motor function recovery in a motorneuron degenerative mouse model. (Q39515636) (← links)
- Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. (Q39910617) (← links)
- Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro (Q40289020) (← links)
- Safety profile of bone marrow mononuclear stem cells in the rehabilitation of patients with posttraumatic facial nerve paralysis-a novel modality (phase one trial). (Q42285233) (← links)
- Isolation of human foetal myoblasts and its application for microencapsulation (Q42913677) (← links)
- Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice (Q45887127) (← links)
- Stem-cell therapies: the first wave. (Q48852540) (← links)
- Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies (Q64463950) (← links)
- Neurotrophic factors and Parkinson's disease (Q82029453) (← links)